FREDS INC FRED Cash Flow

Freds inc (FRED)

CashFlow / TTM

May'19	Feb'19	Oct'18	Jul'18	May'18	Apr'18	Feb'18	Jan'18	Oct'17	Jul'17	Apr'17	Jan'17	Oct'16	Jul'16	Apr'16	Jan'16	Oct'15	Jul'15	Apr'15	Jan'15	Oct'14	Jul'14	Apr'14	Jan'14	Oct'13	Jul'13	Apr'13	Jan'13	Oct'12	Jul'12	Apr'12	Jan'12	Oct'11	Jul'11	Apr'11
Cash flows from operating activities:
Net loss
-146,871	-137,183	-95,319	-120,631	0	-126,623	-144,539	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	0	0	-6,086	-	-11,624	-23,494	-35,051	-28,904	-16,784	958	20,722	26,015	28,605	27,858	30,582	29,629	32,869	35,340	34,372	33,428	0	0	0
Adjustments to reconcile net loss to net cash flows from operating activities:
Depreciation and amortization
26,333	31,273	40,266	40,845	0	41,733	-	42,580	35,021	42,267	43,342	44,014	44,639	44,034	43,780	43,100	44,508	43,370	42,073	41,029	39,896	40,268	40,585	41,047	42,282	41,531	40,478	39,541	38,596	37,125	35,781	34,190	0	0	0
Net gain on asset disposition
3,327	3,624	572	534	0	215	-	275	595	1,290	933	846	621	2,460	2,804	2,887	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Asset impairments
33,527	33,243	4,842	21,818	-	23,853	-	23,853	22,031	27,484	25,285	25,362	25,175	1,138	1,138	1,376	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net gain on asset disposition
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	1,896	1,585	697	471	3,101	2,563	2,967	2,761	0	0	0
Benefit for store closures and asset impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Provision (benefit) for store closures and asset impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-96	-116	-96	112	0	0	0
Stock-based compensation
2,555	3,279	2,686	3,834	0	4,737	-	4,619	11,206	10,309	9,149	8,775	2,735	2,815	2,782	2,247	2,192	1,997	1,987	2,433	1,809	1,941	1,880	1,791	2,557	2,203	2,122	2,055	2,179	2,244	2,143	2,075	0	0	0
(Recovery) for uncollectible receivables
1,315	-25	-1,095	162	0	-549	-	-241	159	-460	-676	-919	-1,278	-1,425	-443	166	1,489	967	1,612	1,383	-236	1,172	228	103	911	350	405	627	0	0	0	-	-	-	-
Provision for uncollectible receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
LIFO reserve increase
0	-	3,331	2,808	0	1,718	-	1,278	2,553	2,645	3,191	5,091	7,166	5,351	8,071	7,545	5,923	5,904	4,521	4,734	4,990	4,121	3,444	4,526	2,867	4,644	3,856	3,937	4,168	3,509	3,109	2,792	0	0	0
Deferred income tax benefit
85	100	-3,392	-3,080	-	-3,068	-	-2,083	3,552	-2,444	-5,407	-7,772	-7,043	-1,663	-2,051	-831	-8,124	-9,386	-11,825	-13,289	-11,186	-11,757	-5,989	-5,165	-4,112	-1,381	-1,964	-583	4,275	5,811	6,414	6,462	0	0	0
Income tax benefit (charge) upon exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-149	-157	-161	-1	-111	-113	-112	-23	0	0	0	-	-	-	-	-	-	-	-
Amortization of debt issuance costs
696	594	523	305	0	352	-	273	208	143	123	105	105	106	610	154	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Increase) decrease in operating assets:
Income tax benefit upon exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Income tax benefit upon exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Trade and non-trade receivables
-8,365	-14,618	-6,771	63	0	-18,881	-	-3,650	2,156	-7,768	8,515	-987	-6,722	-5,010	-18,926	3,570	-1,178	8,190	20,311	-2,153	8,437	4,945	7,152	5,213	10,498	10,269	4,184	8,223	683	4,601	12,699	8,313	0	0	0
Insurance receivables
-	-	119	-321	-	-327	-	-276	-473	587	345	69	212	-361	-113	301	661	630	630	441	16	-360	-298	-298	-517	-131	271	273	313	287	-207	-205	0	0	0
Inventories
-57,396	-17,514	-59,298	-32,738	0	-21,733	-	-28,949	-28,365	-6,305	6,981	11,639	19,844	27,873	29,932	30,351	23,212	-13,283	-38,588	-28,404	-15,018	11,481	17,692	14,953	-4,160	12,801	13,656	25,254	19,144	18,064	32,009	21,402	0	0	0
Other assets
93,931	592	96	1,366	0	-6,903	-	-6,983	-7,426	-5,950	-124	-595	-1,477	-2,060	-1,774	-2,945	-1,170	-1,470	-2,075	-420	-2,240	-189	595	111	3,730	5,537	640	615	-2,702	-3,742	640	-607	0	0	0
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses
-26,034	-41,732	-38,168	-11,245	0	3,055	-	5,083	-52,237	16,688	-21,020	-27,964	-18,466	-7,511	36,100	32,938	73,337	25,883	-1,137	16,689	14,561	18,472	27,701	12,835	1,273	1,122	7,785	8,068	1,484	6,515	9,788	25,464	0	0	0
Income taxes receivable
68	1,255	1,085	1,004	0	1,192	-5	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes payable
-	-	-	-	-	-	-	-	-	-	-	7,175	-591	3,193	-1,962	8,432	6,018	782	-4,188	-13,683	0	0	0	-	5,426	3,268	792	2,627	-4,414	-4,333	1,469	-1,719	0	0	0
Other noncurrent liabilities
43,747	-10,527	-7,274	-7,505	0	-5,494	-	5,907	6,093	9,269	8,298	-2,842	-5,556	-2,801	-1,960	-2,261	-640	7,109	6,141	10,302	10,200	911	350	986	-1,652	-2,455	-4,077	-6,187	-1,513	-321	2,305	1,801	0	0	0
Net cash used in operating activities of continuing operations
-96,771	-91,523	-48,244	-61,600	0	-32,476	-44,703	-	0	0	0	-	-	0	67,362	-	90,613	59,476	37,192	63,703	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	57,670	64,849	47,860	73,330	0	0	0
Cash flows from investing activities of continuing operations:
Cash flows from investing activities of continuing operations:
Capital expenditures
7,981	9,005	10,858	13,396	0	16,098	-	15,753	16,043	18,092	21,454	23,940	27,554	25,625	21,843	22,800	20,984	22,309	20,455	23,308	30,750	29,428	31,940	25,918	20,192	20,045	17,288	20,203	21,149	22,159	20,450	16,770	0	0	0
Capital expenditures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	28,936	29,275	28,196	27,391	27,247	30,378	36,680	45,681	0	0	0
Proceeds from asset dispositions
0	-	-	-	-	-	-	2,206	2,027	3,465	3,863	2,619	2,214	3,927	3,652	3,747	3,752	1,300	4,128	4,861	7,519	7,829	6,395	6,267	3,903	3,523	2,294	1,593	4,183	3,652	3,357	3,354	0	0	0
Insurance recoveries for replacement assets
-	-	-	-	-	-	-	-	-	-	-	416	316	263	263	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Asset acquisitions, net (primarily intangibles)
-	-	-	-	-	-	-	1,718	2,619	5,396	10,853	12,700	15,810	19,220	17,503	16,596	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities of continuing operations
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-44,213	-48,885	-53,773	-59,097	0	0	0
Acquisition of Reeves-Sain Drug Store, Inc., net of cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-9,122	42,750	42,757	42,805	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) investing activities of continuing operations
-	208,667	-7,471	-10,787	-	-14,897	-15,146	-	0	0	0	-	-	0	-35,537	-	-81,985	-91,359	-94,320	-56,052	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from financing activities of continuing operations:
Payments of indebtedness and capital lease obligations
65	64	62	62	0	60	-	59	60	58	57	621	628	636	644	554	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of indebtedness and capital lease obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,343	1,669	1,349	693	667	477	496	514	0	0	0
Proceeds from revolving line of credit
728,378	741,210	737,694	823,942	0	901,131	-	910,181	1,016,340	964,656	1,005,656	990,965	998,400	976,912	911,554	937,164	700,128	601,929	556,121	455,079	426,220	368,822	296,365	235,313	271,105	249,089	164,362	78,444	0	0	0	-	-	-	-
Payments on revolving line of credit
809,128	835,402	724,650	799,883	0	881,771	-	871,081	924,847	930,656	906,075	914,962	935,400	939,757	934,653	902,681	700,129	561,065	489,959	451,236	426,200	355,815	296,348	242,279	271,194	249,186	164,440	71,547	0	0	0	-	-	-	-
Debt issuance costs
420	416	523	433	0	-3,527	-	597	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds (payments) from exercise of stock options and employee stock purchase plan
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Transfer (to) from discontinued operations
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of indebtedness and capital lease obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from other long-term liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax charges from stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Excess tax charges from stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	0	0	0	-	-	-	-
Proceeds (payments) from exercise of stock options and employee stock purchase plan
-	-	-	-	-	45	-	-	-	-	363	553	424	514	572	2,462	1,119	1,115	1,051	-462	1,126	1,134	1,272	1,368	1,176	1,230	1,247	1,109	1,101	975	766	451	0	0	0
Transfer from discontinued operations
-	-	0	0	-	0	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repurchase of shares
-	-	-	-	-	0	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repurchase of shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,120	9,176	9,176	31,806	35,513	28,482	0	0	0
Cash dividends paid
-	-	0	2,283	-	4,567	-	6,847	9,096	9,054	9,016	8,969	8,963	8,960	8,943	8,929	8,901	8,876	8,858	8,846	8,840	8,839	8,833	8,830	15,793	15,781	15,776	15,857	8,535	8,262	8,033	7,713	0	0	0
Net cash (used in ) provided by financing activities of continuing operations
-112,222	-118,364	44,240	59,891	0	34,584	48,047	-	0	0	0	-	-	0	-32,176	-	-9,580	30,759	56,058	-7,936	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in cash and cash equivalents
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flow from discontinued operations
Cash flows from operating activities of discontinued operations, net
-24,703	-17,695	-15,405	-8,469	0	7,999	-	8,547	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from investing activities of discontinued operations, net
-	0	38,500	38,338	-	-800	-	-820	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from financing activities of discontinued operations, net
25,021	17,695	-23,095	-29,869	0	-7,517	-	-7,727	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-17,316	-39,643	-43,320	-36,285	0	0	0
Net increase (decrease) in cash and cash equivalents
788	-1,220	1,070	49	0	-244	-	743	-580	-449	-128	-87	-951	-783	-351	-523	-952	-1,124	-1,070	-285	-13,990	151	394	-1,404	5,466	-15,184	-24	-19,001	-3,859	-23,679	-49,233	-22,052	0	0	0
Net decrease in cash and cash equivalents
-	-	327	-694	-	-1,305	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
788	-1,220	1,070	49	0	-244	-	743	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
788	-1,220	1,070	49	0	-244	-	743	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash and cash equivalents
-	-	327	-694	-	-1,305	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosures of cash flow information:
Interest paid
6,873	7,747	7,707	7,054	0	6,998	-	6,297	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,684	-	1,162	917	631	504	515	521	487	487	524	540	547	549	536	507	464	397	0	0	0
Income taxes refunded
-	-1,648	281	-755	0	-1,770	-	-1,721	-10,215	-8,830	-11,593	-9,906	-5,534	-19,232	-12,537	-12,911	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	17,587	17,308	17,781	15,447	14,266	13,967	12,857	13,126	0	0	0
Acquisition related note payable, see Note 11 - Business Combinations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,000	13,000	13,000	13,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition related contingent liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Assets acquired through term loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,497	0	0	0
Restricted stock issued for the aquistion of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	135	0	0	0